NO995667L - Medisinske aerosolprodukter - Google Patents

Medisinske aerosolprodukter

Info

Publication number: NO995667L
Authority: NO; Norway
Prior art keywords: ciclesonide; butyl; formulations; aerosol products; medical aerosol
Prior art date: 1997-05-21

Application number

NO995667A

Other languages

English (en)

Other versions

NO327716B1 (no

NO995667D0 (no

Inventor

Martin J Oliver

Kanu M Fatania

John S Scott

Helgert Mueller

Original Assignee

Minnesota Mining & Mfg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-21

Filing date

1999-11-18

Publication date

1999-11-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26311564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995667(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-05-21 Priority claimed from GBGB9710496.2A external-priority patent/GB9710496D0/en

1998-02-25 Priority claimed from GBGB9803990.2A external-priority patent/GB9803990D0/en

1999-11-18 Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg

1999-11-18 Publication of NO995667D0 publication Critical patent/NO995667D0/no

1999-11-18 Publication of NO995667L publication Critical patent/NO995667L/no

2009-09-14 Publication of NO327716B1 publication Critical patent/NO327716B1/no

Links

239000000443 aerosol Substances 0.000 title 1
238000009472 formulation Methods 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 abstract 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
229960003728 ciclesonide Drugs 0.000 abstract 2
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
239000006184 cosolvent Substances 0.000 abstract 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
-1 isobutanoyl Chemical group 0.000 abstract 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
239000008249 pharmaceutical aerosol Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
239000003380 propellant Substances 0.000 abstract 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
150000003431 steroids Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Materials For Medical Uses (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Steroid Compounds (AREA)
Thermotherapy And Cooling Therapy Devices (AREA)

NO995667A 1997-05-21 1999-11-18 Farmasøytisk sammensetning, produkt og aerosolformulering NO327716B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9710496.2A GB9710496D0 (en)	1997-05-21	1997-05-21	Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en)	1998-02-25	1998-02-25	Medicinal aerosol products
PCT/US1998/010155 WO1998052542A1 (en)	1997-05-21	1998-05-18	Medicinal aerosol products

Publications (3)

Publication Number	Publication Date
NO995667D0 NO995667D0 (no)	1999-11-18
NO995667L true NO995667L (no)	1999-11-18
NO327716B1 NO327716B1 (no)	2009-09-14

Family

ID=26311564

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO995667A NO327716B1 (no)	1997-05-21	1999-11-18	Farmasøytisk sammensetning, produkt og aerosolformulering
NO2009024C NO2009024I2 (no)	1997-05-21	2009-10-26	IUPAC (2'R)-2' -sykloheksyl-llbeta-hydroksy-21-isobutyryloksy-16bH-dioksolo[5',4'.16,17]pregna-1,4-dien-3,20-dion

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2009024C NO2009024I2 (no)	1997-05-21	2009-10-26	IUPAC (2'R)-2' -sykloheksyl-llbeta-hydroksy-21-isobutyryloksy-16bH-dioksolo[5',4'.16,17]pregna-1,4-dien-3,20-dion

Country Status (27)

Country	Link
US (1)	US6120752A (no)
EP (1)	EP0983058B1 (no)
JP (4)	JP2001526685A (no)
KR (1)	KR100527643B1 (no)
CN (1)	CN1149073C (no)
AT (1)	ATE245966T1 (no)
AU (1)	AU726835B2 (no)
BG (1)	BG64268B1 (no)
BR (1)	BR9809448A (no)
CA (1)	CA2290521C (no)
CZ (1)	CZ298253B6 (no)
DE (1)	DE69816811T2 (no)
DK (1)	DK0983058T3 (no)
EA (1)	EA002381B1 (no)
ES (1)	ES2205491T3 (no)
HU (1)	HU226694B1 (no)
IL (1)	IL132738A (no)
ME (1)	ME01631B (no)
NO (2)	NO327716B1 (no)
NZ (1)	NZ500874A (no)
PL (1)	PL191523B1 (no)
PT (1)	PT983058E (no)
RS (1)	RS49628B (no)
SK (1)	SK283930B6 (no)
TR (1)	TR199902863T2 (no)
UA (1)	UA58551C2 (no)
WO (1)	WO1998052542A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7105152B1 (en)	1991-12-18	2006-09-12	3M Innovative Properties Company	Suspension aerosol formulations
US7101534B1 (en)	1991-12-18	2006-09-05	3M Innovative Properties Company	Suspension aerosol formulations
US6315985B1 (en)	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026073A1 (es) *	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) *	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002798D0 (en) *	2000-02-09	2000-03-29	Glaxo Group Ltd	Actuator nozzle for metered dose inhaler
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
GB0207899D0 (en) *	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and cielesonide aerosol formulations
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
WO2004033478A2 (en) *	2002-10-08	2004-04-22	Sepracor Inc.	Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
ATE556124T1 (de) *	2002-10-25	2012-05-15	Honeywell Int Inc	Fluorsubstituierte olefine enthaltendezusammensetzungen
PT1572217E (pt) *	2002-12-12	2008-11-28	Nycomed Gmbh	Medicamento combinado de r,r-formoterol e ciclesonida
MY143936A (en) *	2003-03-27	2011-07-29	Nycomed Gmbh	Process for preparing crystalline ciclesonide with defined particle size
US20060293293A1 (en) *	2003-05-22	2006-12-28	Altana Pharma Ag	Salmeterol and ciclesonide combination
EP1635845A1 (en) *	2003-06-13	2006-03-22	ALTANA Pharma AG	Formoterol and ciclesonide combination
US8371292B2 (en) *	2003-09-16	2013-02-12	Nycomed Gmbh	Use of ciclesonide for the treatment of respiratory diseases
GB2406283B (en)	2003-09-24	2006-04-05	Altana Pharma Ag	Compliance monitor and method
US9308199B2 (en)	2004-04-29	2016-04-12	Honeywell International Inc.	Medicament formulations
AR041873A1 (es) *	2003-10-30	2005-06-01	Pablo Cassara Srl Lab	Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) *	2003-12-16	2005-11-08	Nycomed Gmbh	Suspensiones acuosas de ciclesonida para nebulizacion
CA2550811C (en) *	2003-12-24	2012-05-01	Jane Hirsh	Temperature-stable formulations, and methods of development thereof
AU2005235384B2 (en) *	2004-04-20	2010-09-09	Covis Pharma B.V.	Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1796679A1 (en) *	2004-09-10	2007-06-20	Altana Pharma AG	Ciclesonide and syk inhibitor combination and methods of use thereof
CN103462894A (zh) *	2005-03-16	2013-12-25	霍尼韦尔国际公司	药物递送制剂、装置和方法
WO2007068007A1 (en) *	2005-12-07	2007-06-14	Harm Benjamin Steyn	Use of a disinfectant for treating respiratory tract infections
DK2425820T3 (en)	2007-02-11	2015-07-13	Map Pharmaceuticals Inc	A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
US20100120737A1 (en) *	2008-11-10	2010-05-13	Martin Feth	Amorphous ciclesonide
EP2407476B1 (en) *	2009-03-09	2014-05-07	Mikasa Seiyaku Co,. Ltd.	Steroid compound
WO2011135585A2 (en)	2010-04-28	2011-11-03	Cadila Healthcare Limited	Aqueous pharmaceutical solution of ciclesonide
MX2013004137A (es) *	2010-10-12	2013-07-29	Cipla Ltd	Composicion farmaceutica.
EP2744479A1 (en)	2011-08-18	2014-06-25	Takeda GmbH	Pharmaceutical aerosol product for administration by oral or nasal inhalation
CN102335132A (zh) *	2011-10-12	2012-02-01	中山大学	一种细辛脑吸入气雾剂及其制备方法
US9603906B2 (en)	2012-02-01	2017-03-28	Protalix Ltd.	Inhalable liquid formulations of DNase I
EP3421042B1 (en)	2012-03-07	2024-04-17	Beyond Air Ltd	Inhalation of nitric oxide for treating respiratory diseases
WO2016057693A1 (en)	2014-10-10	2016-04-14	Alnylam Pharmaceuticals, Inc.	Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2077229B (en) *	1980-05-16	1983-08-03	Neotechnic Eng Ltd	Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) *	1988-10-22	1988-11-30	Fisons Plc	Device
US5225183A (en) *	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
GB8900267D0 (en) *	1989-01-06	1989-03-08	Riker Laboratories Inc	Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) *	1989-09-20	1989-11-08	Riker Laboratories Inc	Medicinal aerosol formulations
IE67185B1 (en) *	1990-02-02	1996-03-06	Fisons Plc	Propellant compositions
DE4003272A1 (de) *	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
CA2077354A1 (en) *	1990-03-23	1991-09-24	Minnesota Mining And Manufacturing Company	Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
GR1001529B (el) *	1990-09-07	1994-03-31	Elmuquimica Farm Sl	Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
AU658854B2 (en) *	1990-10-18	1995-05-04	Minnesota Mining And Manufacturing Company	Aerosol formulation comprising beclomethasone 17,21 dipropionate
US5653962A (en) *	1991-12-12	1997-08-05	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5474758A (en) *	1993-07-28	1995-12-12	Minnesota Mining And Manufacturing Company	Seals for use in an aerosol delivery device
PT735884E (pt) *	1993-12-20	2000-09-29	Minnesota Mining & Mfg	Formulacoes de aerossol de flunisolida
DE19541689A1 (de) *	1994-11-14	1996-05-15	Byk Gulden Lomberg Chem Fab	Kombinationsarzneimittel
US5653961A (en) *	1995-03-31	1997-08-05	Minnesota Mining And Manufacturing Company	Butixocort aerosol formulations in hydrofluorocarbon propellant
SI0820279T1 (en) *	1995-04-14	2002-12-31	Smithkline Beecham Corporation	Metered dose inhaler for albuterol
CA2218179A1 (en) *	1995-04-14	1996-10-17	Glaxo Wellcome Inc.	Metered dose inhaler for beclomethasone dipropionate
JPH11509434A (ja) *	1995-04-14	1999-08-24	グラクソ、ウェルカム、インコーポレーテッド	サルメテロール用計量投与用吸入器

1998
- 1998-05-13 US US09/076,958 patent/US6120752A/en not_active Expired - Lifetime
- 1998-05-18 DK DK98922409T patent/DK0983058T3/da active
- 1998-05-18 PT PT98922409T patent/PT983058E/pt unknown
- 1998-05-18 BR BR9809448-3A patent/BR9809448A/pt not_active Application Discontinuation
- 1998-05-18 CZ CZ0412499A patent/CZ298253B6/cs not_active IP Right Cessation
- 1998-05-18 JP JP55049498A patent/JP2001526685A/ja active Pending
- 1998-05-18 RS YUP-598/99A patent/RS49628B/sr unknown
- 1998-05-18 CA CA002290521A patent/CA2290521C/en not_active Expired - Lifetime
- 1998-05-18 UA UA99116244A patent/UA58551C2/uk unknown
- 1998-05-18 EP EP98922409A patent/EP0983058B1/en not_active Expired - Lifetime
- 1998-05-18 DE DE69816811T patent/DE69816811T2/de not_active Expired - Lifetime
- 1998-05-18 KR KR10-1999-7010773A patent/KR100527643B1/ko not_active Expired - Lifetime
- 1998-05-18 CN CNB98805261XA patent/CN1149073C/zh not_active Expired - Lifetime
- 1998-05-18 AT AT98922409T patent/ATE245966T1/de active
- 1998-05-18 AU AU74962/98A patent/AU726835B2/en not_active Expired
- 1998-05-18 ES ES98922409T patent/ES2205491T3/es not_active Expired - Lifetime
- 1998-05-18 WO PCT/US1998/010155 patent/WO1998052542A1/en not_active Ceased
- 1998-05-18 ME MEP-1999-598A patent/ME01631B/me unknown
- 1998-05-18 SK SK1576-99A patent/SK283930B6/sk not_active IP Right Cessation
- 1998-05-18 EA EA199900991A patent/EA002381B1/ru not_active IP Right Cessation
- 1998-05-18 NZ NZ500874A patent/NZ500874A/en not_active IP Right Cessation
- 1998-05-18 TR TR1999/02863T patent/TR199902863T2/xx unknown
- 1998-05-18 PL PL336885A patent/PL191523B1/pl unknown
- 1998-05-18 HU HU0002691A patent/HU226694B1/hu active Protection Beyond IP Right Term
- 1998-05-18 IL IL13273898A patent/IL132738A/en not_active IP Right Cessation
1999
- 1999-11-18 NO NO995667A patent/NO327716B1/no not_active IP Right Cessation
- 1999-11-19 BG BG103902A patent/BG64268B1/bg unknown
2009
- 2009-10-26 NO NO2009024C patent/NO2009024I2/no unknown
2010
- 2010-12-03 JP JP2010270854A patent/JP2011102301A/ja not_active Withdrawn
2014
- 2014-09-16 JP JP2014187710A patent/JP6087882B2/ja not_active Expired - Lifetime
2016
- 2016-05-19 JP JP2016100499A patent/JP6178459B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2205491T3 (es)	2004-05-01
NO327716B1 (no)	2009-09-14
NO995667D0 (no)	1999-11-18
ATE245966T1 (de)	2003-08-15
NZ500874A (en)	2001-09-28
WO1998052542A1 (en)	1998-11-26
DE69816811T2 (de)	2004-04-15
HU226694B1 (en)	2009-06-29
HUP0002691A3 (en)	2001-04-28
JP2016169222A (ja)	2016-09-23
IL132738A0 (en)	2001-03-19
US6120752A (en)	2000-09-19
ME01631B (me)	2007-08-03
IL132738A (en)	2004-06-20
HK1027027A1 (en)	2001-01-05
CA2290521A1 (en)	1998-11-26
JP2001526685A (ja)	2001-12-18
BG103902A (en)	2000-05-31
DE69816811D1 (de)	2003-09-04
AU7496298A (en)	1998-12-11
DK0983058T3 (da)	2003-11-24
CN1149073C (zh)	2004-05-12
UA58551C2 (uk)	2003-08-15
PL191523B1 (pl)	2006-06-30
NO2009024I2 (no)	2010-08-16
SK283930B6 (sk)	2004-05-04
KR20010012810A (ko)	2001-02-26
JP2011102301A (ja)	2011-05-26
CA2290521C (en)	2006-10-10
RS49628B (sr)	2007-08-03
EA002381B1 (ru)	2002-04-25
JP2015024999A (ja)	2015-02-05
BR9809448A (pt)	2000-06-20
SK157699A3 (en)	2000-05-16
EP0983058B1 (en)	2003-07-30
HUP0002691A2 (hu)	2001-02-28
PL336885A1 (en)	2000-07-17
BG64268B1 (bg)	2004-08-31
EA199900991A1 (ru)	2000-08-28
KR100527643B1 (ko)	2005-11-15
YU59899A (sh)	2002-06-19
AU726835B2 (en)	2000-11-23
JP6178459B2 (ja)	2017-08-09
EP0983058A1 (en)	2000-03-08
NO2009024I1 (no)	2009-10-26
JP6087882B2 (ja)	2017-03-01
PT983058E (pt)	2003-12-31
CZ412499A3 (cs)	2000-02-16
CZ298253B6 (cs)	2007-08-08
TR199902863T2 (xx)	2000-05-22
CN1257421A (zh)	2000-06-21

Legal Events

Date	Code	Title	Description
2010-08-16	SPCG	Granted supplementary protection certificate	Free format text: PRODUCT NAME: ALVESCO; NAT. REG. NO/DATE: MT NO. 04-2868 (71+72) 20050107; FIRST REG. NO/DATE: PL20141/0004-0006 20040416 Spc suppl protection certif: 2009024 Filing date: 20091026 Extension date: 20190416
2013-04-02	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: 3M INNOVATIVE PROPERTIES CO, DE
2016-02-08	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: 3M INNOVATIVE PROPERTIES CO, DE
2018-06-11	MK1K	Patent expired
2019-01-02	SPCS	Change of name or address of the owner of a supplementary protection certificate	Owner name: 3M INNOVATIVE PROPERTIES CO, DE Spc suppl protection certif: 2009024
2019-05-13	SPCX	Expiry of an spc	Spc suppl protection certif: 2009024

Publication	Publication Date	Title
DK0983058T3 (da)	2003-11-24	Medicinske aerosolprodukter
ATE353629T1 (de)	2007-03-15	Cannabis enthaltende pharmazeutische zusammensetzungen
DE60322200D1 (de)	2008-08-28	Formoterol und ciclesonid aerosol-formulierungen
DK1303258T3 (da)	2007-01-22	Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
BR9916829A (pt)	2001-10-23	Formulações aerossóis farmacêuticas contendo fluoroalcanos, budesonida e formoterol
NZ240237A (en)	1994-06-27	An aerosol formulation (free of surfactant) for treatment of asthma comprising: a hydrofluorocarbon propellant, ethanol, and beclomethasone 17,21 dipropionate; preparation thereof
HUP0102102A2 (hu)	2002-03-28	Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
KR970706021A (ko)	1997-11-03	N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
CL2004001325A1 (es)	2005-06-03	Una composicion farmaceutica de aerosol que comprende cilesonida solubilizada en un propelente hidrofluorocarbono y un co-solvente, de preferencia etanol, util como antiinflamatorio de las vias aereas.
HUP9900849A2 (hu)	1999-09-28	Eljárás danazol által kiváltott csonttömegvesztés minimalizálására alkalmas gyógyszerkészítmények előállítása
HUP0001773A2 (hu)	2000-11-28	Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
HUP0004701A2 (hu)	2002-11-28	Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
ATE184875T1 (de)	1999-10-15	Imidazo(1,2-a>indeno(1,2-e>pyrazin-2-carbonsäur derivate, ihre herstellung und sie enthaltende arzneimittel
JPS6322011A (ja)	1988-01-29	口腔用衛生組成物
JPH0977640A (ja)	1997-03-25	発毛・育毛料
JPS63264522A (ja)	1988-11-01	消炎鎮痛剤用エアゾ−ル組成物
TH59375A3 (th)	2003-11-14	สูตรผสมทางเภสัช ที่ซึ่งการปลดปล่อยออกได้ถูกควบคุม
TH28989B (th)	1998-06-25	เททราไซคลิค ไทรเทอร์ปีน